Cognition Therapeutics
CGTX
CGTX
51 hedge funds and large institutions have $4.89M invested in Cognition Therapeutics in 2025 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
17% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 12
37% less capital invested
Capital invested by funds: $7.78M → $4.89M (-$2.89M)
Holders
51
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$376K | |
| 2 | +$84.2K | |
| 3 | +$23.6K | |
| 4 |
EFS
Essex Financial Services
Essex,
Connecticut
|
+$16.7K |
| 5 |
NFC
Northeast Financial Consultants
Westport,
Connecticut
|
+$16.3K |
Top Sellers
| 1 | -$351K | |
| 2 | -$56K | |
| 3 | -$22.4K | |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$21.2K |
| 5 |
VC
Voss Capital
Houston,
Texas
|
-$21K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BCM
51
Bridgeway Capital Management
Houston,
Texas
| – |
|
|||
52
Jane Street
New York
| – |
|